Successful treatment of <em>Staphylococcus haemolyticus</em> endocarditis in extremely premature baby with daptomycin
Vol. 8 No. 1 (2019), Articles
Vol. 8 No. 1 (2019)

Successful treatment of <em>Staphylococcus haemolyticus</em> endocarditis in extremely premature baby with daptomycin

Articles
https://doi.org/10.7363/080109
Published 2018-11-27
Suzan Suhail Asfour
Clinical Pharmacy Department, Pharmacy Department, King Saud Medical City, Riyadh, Saudi Arabia
Fahad Aljobair
Infectious Disease Department, Hospital of Pediatrics, King Saud Medical City, Riyadh, Saudi Arabia
Ibrahim Hammami
Pediatric Pharmacy, Pharmacy Department, King Saud Medical City, Riyadh, Saudi Arabia
Adli Abdelrahim
Neonatology, Hospital of Pediatrics, King Saud Medical City, Riyadh, Saudi Arabia
Mountasser M. Al-Mouqdad
Neonatology, Hospital of Pediatrics, King Saud Medical City, Riyadh, Saudi Arabia
PDF

Keywords

endocarditis
daptomycin
neonate
premature
Staphylococcus haemolyticus
sepsis

How to Cite

Asfour, S. S., Aljobair, F., Hammami, I., Abdelrahim, A., & Al-Mouqdad, M. M. (2018). Successful treatment of <em>Staphylococcus haemolyticus</em> endocarditis in extremely premature baby with daptomycin. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM), 8(1), e080109. https://doi.org/10.7363/080109
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Daptomycin is a novel lipopeptide antibiotic with rapid activity against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus, coagulase-negative Staphylococci, and Enterococci. We are reporting the first case of successfully using daptomycin to treat infective endocarditis in an extremely premature baby.
https://doi.org/10.7363/080109
PDF